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Abstract
AIM: To determine the effect of free serotonin concen-
trations in plasma on development of esophageal and 
gastric fundal varices.
METHODS: This prospective study included 33 patients 
with liver cirrhosis and 24 healthy controls. Ultrasonog-
raphy and measurement of serotonin concentration in 
plasma were carried out in both groups of subjects. The 
upper fiber panendoscopy was performed only in pa-
tients with liver cirrhosis.
RESULTS: The mean plasma free serotonin levels were 
much higher in liver cirrhosis patients than in healthy 
controls (219.0 ± 24.2 nmol/L vs  65.4 ± 18.7 nmol/L, 
P  < 0.0001). There was no significant correlation be-
tween serotonin concentration in plasma and the size 
of the esophageal varices according to Spearman coef-
ficient of correlation (r s = -0.217, P  > 0.05). However, 
the correlation of plasma serotonin concentration and 
gastric fundal varices was highly significant (r s = -0.601, 
P  < 0.01).
CONCLUSION: Free serotonin is significant in patho-
genesis of portal hypertension especially in develop-
ment of fundal varices, indicating the clinical value of 
serotonergic receptor blockers in these patients.
© 2010 Baishideng. All rights reserved.
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INTRODUCTION
Portal hypertension has been increasingly regarded as a 
multi-organ disease with complex blood flow changes in 
the systemic and splanchnic vascular network. 
The hepatic stellate cell (HSC) has a significant posi-
tion in the sinusoid for regulation of  portal flow. During 
liver damage, HSCs are “activated” which leads to HSC 
transformation into myofibroblast-like cells with a result-
ing increased collagen production[1,2]. Several mitogens are 
included in the triggering of  HSC proliferation: platelet-
derived growth factor (PDGF), insulin-like growth factor 
1 and connective-tissue growth factor. During activation, 
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HSCs acquire the ability to express PDGF receptors on 
the cell membrane surface[3]. The HSC membrane con-
tains numerous receptors whose expression is increased 
with the extent of  liver damage, to which different va-
soconstrictors are bound: catecholamines, endothelin, 
angiotensin Ⅰ and Ⅱ, leukotrienes and serotonin [5-hy-
droxytriptamin (5-HT)][4,5]. 
Serotonin, at the level of  hepatic sinusoids, causes en-
dothelial fenestrae contractions of  liver sinusoids through 
5-HT1 receptors mediated by a Ca2+-dependent process. 
Due to different proinflammatory mediators releasing 
from the damaged liver, it comes to platelet adherence to 
sinusoidal endothelium, translocation into Disse’s space 
and serotonin release. Thereafter, serotonin binds to re-
ceptors (5-HT2A, 5-HT1B, 5-HT1F and 5-HT7) which are 
expressed on HSC and hepatocytes, which additionally 
interferes with HSC proliferation[6,7]. 
The aim of  our study was to determine to what extent 
a free serotonin concentration in plasma has an effect on 
development of  esophageal and gastric fundal varices.
MATERIALS AND METHODS
The study included 33 patients with liver cirrhosis who 
were examined and treated at the Clinic of  Gastroenter-
ology, Clinical Center of  Serbia, and 24 healthy subjects 
who made up the control group. The study was prospec-
tive and conducted during the period 2008-2009.
Ultrasonography was carried out by Toshiba Core Vi-
sion, with 3.5 MHz duplex Doppler convex tube in a stan-
dard procedure. Ultrasonography examined the liver size, 
echo structure of  the hepatic parenchyma and possible 
focal changes with a view to rule out the patients with 
primary and secondary liver tumors from the study. To 
determine the spleen size, standard parameters were used, 
according to which in physiological conditions the spleen 
diameter measured in the X intercostal space exceeded no 
more than 12.0 cm and anteroposterior diameter was not 
over 5.0 cm.
The upper endoscopy was performed by endo-video 
system Olympus GIF-Q 165. To measure the esophageal 
varices size, Paquet’s classification was used: Ⅰ degree-
lesser snake-like mucosal protrusions, Ⅱ degree-varices 
were predominating up to a half  of  the esophageal lumen 
radius, Ⅲ degree-varices were in contact at some points, 
and Ⅳ degree-heralds of  the imminent rupture (cherry 
red spots)[8]. Endoscopic examination showed portal hy-
pertensive gastropathy (snake skin mucosa) and varices of  
the gastric fundus.
Platelet poor plasma (PPP) was obtained from the 
venous blood which was collected in 3 mL original Va-
cutainer “BD” tubes, with 75 g/L K3EDTA 0.072 mL. 
Blood samples were taken between 8 and 9 a.m. Platelet 
rich plasma (PRP) was obtained by low speed centrifuga-
tion (200 g, 10 min) on “Heraeus Digifuga GL”. Exactly 
1 mL of  PRP was centrifuged at 1000 g, 10 min. The 
obtained PPP was separated and stored at -20℃ for no 
longer than 20 d[9].
 The number of  PPP serotonin samples was estimated 
in one series. One hundred μL plasma samples were spiked 
with 10 μL of  original N-methyl serotonin solution (Recipe, 
Munchen), which was an internal standard. After that, PPP 
samples were deproteinized with 100 μL original depro-
teinating reagent (Recipe, München), and centrifuged at 
10 000 g[10]. The obtained 20 μL supernatants were analyzed 
on reverse phase HPLC column (Recipe, München), with 
original mobile phase for serotonin (Recipe, München). 
Original “Recipe” external standard solution was used for 
calibration. The HPLC system consisted of  “Bio-Rad AS 
100” HRLC automatic sampling system with “Rheodine 
7125 valve”, “Bio-Rad 1350” HPLC pump and “Bio-Rad 
1640” electrochemical detection. Chromatographic data 
were calculated using the “Chrome Line V 4.20” HPLC 
software. Amperometric detection was done at 0.6 V. The 
duration of  chromatographic separation was 10 min. 
Statistical analysis was performed using the Statistical 
Package for Social Sciences (SPSS®, version 17.0). Basic 
descriptive statistics included means, standard deviations, 
ranges and percentages. Differences between groups were 
compared with parametric t-test because data had a Gauss-
ian distribution. Correlation analysis was processed via the 
Spearman method. Values at the P ≤ 0.05 level were con-
sidered statistically significant.
RESULTS
The study included 11 (33.3%) female and 22 (66.7%) 
male patients, mean age of  52.32 (SD ± 11.55) years. The 
most common cause of  liver cirrhosis was alcohol-in 15 
(45.4%) cases. The incidence of  posthepatitic cirrhosis 
was lower; HCV-8 (24.2%), HBV-5 (15.1%), while autoim-
mune diseases were quite rare-in 5 (15.1%) patients.
Splenomegaly was detected in 28 (84.8%) patients with 
liver cirrhosis. An average longitudinal splenic diameter 
was 17.5 ± 3.57 cm, and transversal diameter was 6.8 ± 
1.77 cm, which was significantly different in relation to 
the controls, in whom an average longitudinal diameter 
was 10.21 ± 1.65 cm and transversal diameter was 3.03 ± 
0.87 cm (t-test, P < 0.05). 
There was a highly significant difference between 
the platelet count in the studied groups of  patients (t = 
-9.779, P < 0.01).
The mean plasma free serotonin level was much high-
er in liver cirrhosis patients than in healthy controls (219.0 
± 24.2 nmol/L vs 65.4 ± 18.7 nmol/L; t-test, P < 0.0001). 
There was no significant correlation between sero-
tonin concentration in plasma and the platelet count ac-
cording to Spearman coefficient of  correlation (rs = 0.158, 
P > 0.05).
Esophageal varices were not detected in 5 (15.1%) pa-
tients, grade Ⅰ-Ⅱ varices were detected in 9 (27.2%), grade 
Ⅱ-Ⅲ in 15 (45.4%) and the remaining 4 patients (12.1%) 
were grade Ⅳ. Gastric fundal varices were found in 7 (21.2%) 
patients, out of  whom 2 had Ⅰ-Ⅱ, 4 had grade Ⅱ-Ⅲ 
esophageal varices, and one patient had Ⅳ degree varices.
Spearman’s rank correlation verified a statistically sig-
nificant correlation between the platelet count and varices 
size (rs = -0.479, P < 0.05).
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Spearman’s rank correlation verified no significant dif-
ference between the serotonin concentration in plasma in 
relation to the size of  esophageal varices (rs = -0.217, P > 
0.05). However, the mean plasma free serotonin level was 
higher in patients with esophageal varices than in patients 
without varices (t = -2.301, P < 0.05). Furthermore, the 
correlation of  plasma serotonin concentration and fundal 
varices was highly significant (rs = -0.601, P < 0.01). Also, 
we proved that the mean plasma free serotonin level was 
much higher in patients who had esophageal and gastric 
fundal varices than in patients who had only esophageal 
varices (t = -5.862, P < 0.01).
DISCUSSION
Different factors may affect the concentrations of  cir-
culating serotonin in liver cirrhosis, such as: impaired 
serotonin catabolism due to higher activity of  the mono-
amino oxidases; impaired metabolism of  tryptophane as 
a serotonin precursor; platelet sequestration in the spleen 
and/or platelet activation[11]. In addition, 5-HT as well as 
other vasoactive substances synthesized in the gastroin-
testinal tract via porto-systemic collaterals bypass the liver 
and directly enter the systemic circulation[12]. 
In the study of  Beaudry et al[13], in 1994, the whole-
blood serotonin levels were significantly lower in 30 
patients with cirrhosis than in the age-matched controls, 
and no correlation was found between these levels and 
the severity of  cirrhosis. However, in the same study the 
unconjugated plasma serotonin levels, an indication of  
the active form of  serotonin, were significantly higher in 
patents with cirrhosis than in the controls.
In our previous study, free or unconjugated sero-
tonin levels were investigated. The levels of  free sero-
tonin were higher in patients with liver cirrhosis than in 
healthy subjects[14]. 
In the study of  Vorobioff et al[15], in 1989, it was con-
firmed that the application of  ketanserin and ritanserin 
(serotonergic receptor inhibitors) caused the lowering of  
portal hypertension in patients with liver cirrhosis. The au-
thors reported that the spleen congestion in liver cirrhosis 
brought about the platelet breakdown. Free serotonin, 
released in the sinusoidal spaces of  the spleen, induced 
by S-2 receptor produced an intense vasoconstricting re-
sponse in portal circulation which led to maintenance and 
elevation of  the portal pressure. Moreover, it was docu-
mented that the reaction of  the isolated mesenteric vein in 
rats with portal hypertension to 5-HT was hypersensitive, 
which was additional evidence of  the role of  this sub-
stance in pathogenesis of  portal hypertension. 
In our study, the correlation of  unconjugated sero-
tonin concentration (active form of  serotonin) in plasma 
and varices of  the gastric fundus was highly significant 
while the plasma unconjugated serotonin concentration 
did not correlate with the size of  the esophageal varices. 
Moreover, mean longitudinal and transversal diameters 
of  the spleen in patients was significantly higher as com-
pared to controls.
The spleen has a crucial role in pathogenesis and 
maintenance of  portal hypertension[16,17]. In portal hyper-
tension, the anatomic changes of  the spleen (pulp hyper-
plasia, congestion and fibrosis) and specific vascularization 
affect the hemodynamics of  the splenic circulation[18].
Our finding may be accounted for different porto-
systemic collateral pathways in esophageal and fundal 
varices as well as valuable flow changes in the left part 
of  the portal venous system. Perisic et al[19] reported, in 
2005, that the splenic vein flow in patients with liver cir-
rhosis was slower in comparison with healthy controls. 
In addition, in healthy controls, the splenic vein flow was 
significantly slower than in the portal vein. However, in 
patients with liver cirrhosis splenic vein flow was signifi-
cantly faster than in the portal vein, probably because of  
the splenic venous congestion and compensatory hemo-
dynamic mechanisms of  the spleen.
Gastric varices are drained through the short gastric 
veins into the splenic vein. Serotonin released by platelet 
sequestration in the enlarged spleen reaches the lienal vein 
where the blood flow is faster than in the portal vein, and 
directly, via short gastric veins, it enters the fundal gastric 
veins, leading to vasoconstriction.
Our conclusion is that free serotonin is significant in 
pathogenesis of  portal hypertension especially in develop-
ment of  gastric fundal varices which may have clinical val-
ue in use of  serotonin receptor blockers in these patients. 
COMMENTS
Background
In acute and chronic hepatic insufficiency, the serotonin system changes lead to 
development of hepatic encephalopathy, portal hypertension and hyperdynamic 
circulation. Portal hypertension has been increasingly regarded as a multi-organ 
disease with complex blood flow changes in systemic and splanchnic vascular 
network. The hepatic stellate cell (HSC) has a significant position in sinusoid for 
regulation of portal flow and during liver damage serotonin binds to receptors 
[5-hydroxytriptamin (5-HT)2A, 5-HT1B, 5-HT1F and 5-HT7] which are expressed on 
HSC and hepatocytes, which additionally interferes with HSC proliferation. 
Research frontiers
Free serotonin, released in the sinusoidal spaces of the spleen, induced by S-2 
receptor, produces an intense vasoconstricting response in the portal circula-
tion, which leads to maintenance and elevation of portal pressure. The highlight 
of our study was to determine to what extent a free serotonin concentration in 
plasma has an effect on development of esophageal and gastric fundal varices.
Innovations and breakthroughs
In the study of Vorobioff et al, in 1989, it was confirmed that the application of 
ketanserin and ritanserin (serotonergic receptor inhibitors) caused the lower-
ing of portal hypertension in patients with liver cirrhosis. Moreover, it was 
documented that the reaction of the isolated mesenteric vein in rats with portal 
hypertension to 5-HT was hypersensitive, which was additional evidence of the 
role of this substance in pathogenesis of portal hypertension. In this study, the 
correlation of unconjugated serotonin concentration (active form of serotonin) 
in plasma and varices of the gastric fundus was highly significant while the 
plasma unconjugated serotonin concentration did not correlate with the size of 
the esophageal varices. The authors’ finding may be accounted for by different 
porto-systemic collateral pathways in the esophageal and fundal varices as well 
as valuable flow changes in the left part of the portal venous system.
Applications 
The conclusion is that free serotonin is significant in pathogenesis of portal hy-
pertension especially in development of gastric fundal varices. This may have 
clinical value in use of serotonin receptor blockers in these patients. 
Terminology
Portal hypertension: Portal hypertension (> 10 mmHg) most commonly results 
from increased resistance to portal blood flow. Cirrhosis is the most common 
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cause of portal hypertension. One of the major clinical manifestations of portal 
hypertension includes life-threatening hemorrhage from gastrointestinal varices. 
Serotonin: Serotonin is a vasoactive substance, synthesized by the intestinal 
enterochromaffin cells, which is actively incorporated into platelets and stored 
in platelet dense-storage granules.
Peer review
The manuscript reports that free serotonin is significant in pathogenesis of por-
tal hypertension especially in development of gastric fundal varices which may 
have clinical value in use of serotonin receptor blockers in these patients. 
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